Keyphrases
RNA Interference
100%
Rodent Models
100%
Therapeutic Targeting
100%
Angiotensinogen
100%
Preeclamptic
100%
Preeclampsia
75%
Proteinuria
75%
Renin-angiotensin System
50%
Small Interfering RNA (siRNA)
25%
Blood Pressure
25%
Deleterious Effects
25%
Hypertension
25%
Systemic Inflammation
25%
Selective Intrauterine Growth Restriction (sIUGR)
25%
Transgenic Mouse Model
25%
Ischemia-reperfusion Injury
25%
Small Molecules
25%
Maternal Morbidity
25%
Maternal Mortality
25%
Angiotensin II Type 1 Receptor (AT1R)
25%
Fetus
25%
Fetal Outcome
25%
Local Inflammation
25%
Week of Gestation
25%
Fetal Growth Restriction
25%
New-onset Hypertension
25%
Fetal Morbidity
25%
Renin-angiotensin System Blockers
25%
Mid-gestation
25%
Angiogenic Imbalance
25%
Placental Blood Flow
25%
Renin
25%
Fetal Toxicity
25%
RNA Therapeutics
25%
RNA Therapy
25%
Clinical Sequelae
25%
Uteroplacental
25%
Fetal Effects
25%
Reduced Uterine Perfusion Pressure
25%
Medicine and Dentistry
Angiotensinogen
100%
RNAi Therapeutics
100%
Pre-Eclampsia
75%
Renin Angiotensin Aldosterone System
75%
Proteinuria
75%
Small Interfering RNA
50%
Pregnancy
25%
Intrauterine Growth Retardation
25%
Biological Marker
25%
Upregulation
25%
Sequela
25%
Blood Pressure
25%
Reperfusion Injury
25%
Blood Flow
25%
Maternal Morbidity
25%
Maternal Mortality
25%
Angiotensin Receptor
25%
Fetus Growth
25%
Renin
25%
Biochemistry, Genetics and Molecular Biology
Renin Angiotensin Aldosterone System
100%
RNAI
100%
Small Interfering RNA
66%
Small Molecule
33%
Prenatal Growth
33%
Blood Pressure
33%
Upregulation
33%
Reperfusion
33%
RNA Interference
33%
Transgenic Organism
33%
Perfusion Pressure
33%
Blood Flow
33%
Angiotensin Receptor
33%
Pregnancy
33%
Maternal Morbidity
33%
Fetus Growth
33%
Maternal Mortality
33%
Renin
33%